highly significantP < 0.0001
Among the 57 ALS and 23 non-ALS patients with evaluable specimens, axonal pTDP-43 was observed in 98.2% of ALS subjects (56 of 57) versus 30.4% of non-ALS subjects (7 of 23), a highly significant difference ( P < 0.0001).